At that time, it was already known that the most common mutated gene in pancreatic cancer was the KRAS oncogene and that other common mutations were mutations affected the genes TP53, DPC4, and BRCA2, which appear later than the KRAS mutation13, 14. This evidence concerns the gene BRCA2 and familial pancreatic carcinoma.